Evidence map›Paper›PMID 25042759›Full record

Trial reportDrug and alcohol dependence2014

Group therapy for women with substance use disorders: results from the Women's Recovery Group Study.

Shelly F Greenfield, Dawn E Sugarman, Cathryn M Freid, Genie L Bailey, Michele A Crisafulli, Julia S Kaufman, Sara Wigderson, Hilary S Connery, John Rodolico, Antonio A Morgan-Lopez and 1 more

Registry-linked trialOpen access · greenAbstract readClinical Trial, Phase IIRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01318538 (Recovery Group for Women With Substance Use Disorders - Stage II Trial), which is not on this map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01318538 nacompletednot on this map

Recovery Group for Women With Substance Use Disorders - Stage II Trial

TypeinterventionalSponsorMclean HospitalRan2008 to 2012Enrolled158ConditionsSubstance-Related Disorders, Alcohol-Related DisordersArmsThe Women's Recovery Group, Group Drug Counseling
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. A randomized trial of female-specific cognitive behavior therapy for alcohol dependent women.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2018
    Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Shelly F GreenfieldMcLean Hospital, Division of Alcohol and Drug Abuse, Belmont, MA 02478, United States; Harvard Medical School, Department of Psychiatry, Boston, MA 02115, United States; McLean Hospital, Division of Women's Mental Health, Belmont, MA 02478, United States. Electronic address: sgreenfield@mclean.harvard.edu.
Dawn E SugarmanMcLean Hospital, Division of Alcohol and Drug Abuse, Belmont, MA 02478, United States; Harvard Medical School, Department of Psychiatry, Boston, MA 02115, United States; McLean Hospital, Division of Women's Mental Health, Belmont, MA 02478, United States.
Cathryn M FreidMcLean Hospital, Division of Alcohol and Drug Abuse, Belmont, MA 02478, United States.
Genie L BaileyBrown University, Department of Psychiatry and Human Behavior, Providence, RI 02912, United States; Stanley Street Treatment and Resources, Fall River, MA 02720, United States.
Michele A CrisafulliUniversity of Maryland, Baltimore County, Department of Psychology, Baltimore, MD 21250, United States.
Julia S KaufmanMiami University, Department of Psychology, Oxford, OH 45056, United States.
Sara WigdersonMcLean Hospital, Division of Alcohol and Drug Abuse, Belmont, MA 02478, United States; McLean Hospital, Division of Women's Mental Health, Belmont, MA 02478, United States.
Hilary S ConneryMcLean Hospital, Division of Alcohol and Drug Abuse, Belmont, MA 02478, United States; Harvard Medical School, Department of Psychiatry, Boston, MA 02115, United States.
John RodolicoMcLean Hospital, Division of Alcohol and Drug Abuse, Belmont, MA 02478, United States; Harvard Medical School, Department of Psychiatry, Boston, MA 02115, United States.
Antonio A Morgan-LopezRTI International, Risk Behavior and Family Research Program, Research Triangle Park, NC 27709, United States.
Garrett M FitzmauriceMcLean Hospital, Division of Alcohol and Drug Abuse, Belmont, MA 02478, United States; Harvard Medical School, Department of Psychiatry, Boston, MA 02115, United States.
McLean Hospital · USHarvard University · USMiami University · USRTI International · USUniversity of Maryland, Baltimore County · US

Funding

The National Drug Abuse Treatment Clinical Trials Network (U10)U10DA015831 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI CARROLL, KATHLEEN M., WEISS, ROGER D. · 2002 to 2015
$28.8M
Recovery Group for Women with Substance Use DisordersR01DA015434 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI GREENFIELD, SHELLY F. · 2002 to 2011
$3.1M
Mentoring in Substance Abuse Treatment ResearchK24DA019855 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI GREENFIELD, SHELLY F. · 2005 to 2014
$1.8M
NIDA NIH HHS K24 DA019855NIDA NIH HHS R01 DA015434NIDA NIH HHS U10 DA015831
6 · The paper itself

Abstract

backgroundThis Stage II trial builds on a Stage I trial comparing the single-gender Women's Recovery Group (WRG) to mixed-gender Group Drug Counseling (GDC) that demonstrated preliminary support for the WRG in treating women with substance use disorders. The Stage II trial aims were to (1) investigate effectiveness of the WRG relative to GDC in a sample of women heterogeneous with respect to substance of abuse and co-occurring psychiatric disorders, and (2) demonstrate the feasibility of implementing WRG in an open-enrollment group format at two sites.

methodIn this randomized clinical trial, participants were included if they were substance dependent and had used substances within the past 60 days (n=158). Women were randomized to WRG (n=52) or GDC (n=48); men were assigned to GDC (n=58). Substance use outcomes were assessed at months 1-6 and 9.

resultsWomen in both the WRG and GDC had reductions in mean number of substance use days during treatment (12.7 vs 13.7 day reductions for WRG and GDC, respectively) and 6 months post-treatment (10.3 vs 12.7 day reductions); however, there were no significant differences between groups.

conclusionsThe WRG demonstrated comparable effectiveness to standard mixed-gender treatment (i.e., GDC) and is feasibly delivered in an open-group format typical of community treatment. It provides a manual-based group therapy with women-focused content that can be implemented in a variety of clinical settings for women who are heterogeneous with respect to their substance of abuse, other co-occurring psychiatric disorders, and life-stage.

Indexed as

WomenAdultCounselingFemaleHumansLongitudinal StudiesMiddle AgedPsychotherapy, GroupSubstance-Related DisordersTreatment OutcomeGender differencesGroup therapySubstance use disordersTreatment outcomesWomen

Identifiers

PMID25042759
PMCPMC4150678
OpenAlexW2041984794

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.